Compare Davita Inc (DVA) vs Oatly Group AB - ADR (OTLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs Oatly Group AB - ADR — how do they compare? Davita Inc trades at $175.04 (market cap $11.28B), while Oatly Group AB - ADR trades at $11.93 (market cap $330.93M). The key difference: Davita Inc is far larger — about 34.1× Oatly Group AB - ADR's market cap, and Davita Inc is more actively traded (650,294 versus 44,023). Which is the better fit depends on your goals — on Pluang, investors hold Davita Inc for 113 Days and Oatly Group AB - ADR for 18 Days on average.
| DVA | OTLY | |
|---|---|---|
Market Cap | $11.28B | $330.93M |
Volume | 650,294 | 44,023 |
Sector | Health | Consumer Staples |
52-Week High | $240.96 | $15.91 |
52-Week Low | $103.87 | $8.03 |
Typical Hold Time | 113 Days | 18 Days |
Enterprise Value | $24.00B | $835.34M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $177.02, down 1.87% on the day, showing mixed technical signals with a bearish moving average trend but neutral oscillators. Fundamentally, the company demonstrates strong earnings beats with Q2 2026 EPS of $4.02 exceeding expectations of $3.88, while revenue growth continues from $13.64B in 2025 to projected $14.0B in 2026. Recent developments include expanding value-based care partnerships with Humana, potentially benefiting over 10,000 Medicare Advantage members.
The outlook remains cautiously optimistic with 43% analyst buy ratings and a $235.67 consensus price target suggesting 33% upside. However, rising debt-to-asset ratios (65.55% in 2025) and margin pressures from Q2 2026 create headwinds. Key risks include regulatory changes in healthcare reimbursement and competitive pressures in dialysis services.
Oatly (OTLY) trades at $10.38, down 1.24% today, with a mixed technical picture showing bearish moving averages but oversold RSI levels. The company continues to report revenue growth ($862M in 2025) but remains unprofitable with a -17.72% net margin. Recent Q2 2026 results showed a revenue beat and improved guidance, driving positive sentiment. Analyst consensus is divided with a $12.28 price target, while cash flow trends show gradual operational improvement despite negative net income.
The outlook remains challenging as Oatly works toward profitability amid high debt levels and negative cash flow. Investment opportunity exists if margin improvements continue and the company achieves positive EBITDA. Key risks include execution on cost controls, competitive pressures in plant-based beverages, and the sustainability of recent revenue growth momentum in a challenging consumer environment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About Oatly Group AB - ADR
Oatly Group AB is engaged in the food and drinks industry. Some of its products include Oat Drink, Chilled Oat Drink, Oatgurt, Creamy Oat, Icecreams, among others. It caters to Sweden, Germany, United Kingdom, Netherlands, North America, Finland, and other markets.
Read more on OTLY →
